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Introduction
Over the last decade, independent reports have suggested
the hypothesis of a potential association between patent
foramen ovale (PFO) and migraine [1, 2]. Although the
exact pathogenic mechanism linking this anatomical vari-
ant to disease occurrence remains elusive at present, data of
literature indicate that the association may be stronger in
the subgroup of patients with migraine with aura (MA+),
than in those with migraine without aura (MA–). Recently,
a similar association has been reported in a relatively small
group of individuals with cluster headache (CH) [3], thus
supporting the assumption that interatrial septal abnormal-
ities might be a predisposing condition for different disor-
ders. In spite of the consistency of these findings, further
studies including larger number of individuals are neces-
sary to substantiate such a hypothesis. Furthermore, sever-
al questions remain to be addressed. In particular, whether
the reported non-significant association between MA– and
PFO is the consequence of an underpowered comparison
and whether any phenotypic difference exists between
migrainous patients with PFO and those without, is still
debatable. Finally, based on the concept of paradoxical
embolism as a link between PFO and cerebral ischaemia,
the possibility that migraine occurrence in subjects with a
PFO may be related to triggering conditions, such as a
strenuous physical activity, has never been tested so far.
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Abstract A relationship between
migraine and patent foramen ovale
(PFO) has been observed in rela-
tively small series of patients so far.
Furthermore, the exact mechanism
underlying such an association
remains unknown. In the present
study we determined the prevalence
of PFO by contrast-enhanced tran-
scranial Doppler (TCD) in a group
of 260 patients with migraine with
aura (MA+), 74 patients with
migraine without aura (MA-), and
38 patients with cluster headache
(CH). One-hundred-sixty-one
MA+subjects (61.9%), 12 MA-sub-
jects (16.2%), and 14 CH-subjects
(36.8%) were PFO-carriers. The
association was independent on the
frequency of migraine attacks and
complexity of aura. Finally, among
the 15 patients who had a history of
at least one migraine attack occur-
ring during a Valsalva maneuver
only one subject turned out to be
PFO-carrier. Our findings confirm
previous observations of a link
between MA+, CH, and PFO. They
also suggest that such an associa-
tion is independent on migraine
clinical phenotype and is probably
unrelated to the pathogenic mecha-
nism of paradoxical embolism.
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Materials and methods
The study group consisted of migrainous patients selected among
those consecutively included in the database of the Headache
Center – Istituto Clinico Città di Brescia, who were re-evaluated
and underwent a PFO determination from January 2004 to
December 2004. Patients fulfilling the International Headache
Society diagnostic criteria [4] for MA–, MA+ and CH were consid-
ered. Only patients with moderate or severe headache intensity
(Visual Analogical scale (VAS) ≥4) were included. For the purpose
of the present study, the monthly frequency of migraine attacks in
the subgroups of patients with MA– and MA+ as well as the com-
plexity of aura in the subgroup of patients with MA+ were assessed
in each patient and included in the analysis as phenotypic variables.
Finally, a further specific subgroup of migraine patients was
selected based on the presumed triggering effect of strenuous phys-
ical exercise on headache occurrence. PFO was assessed in all
patients with TCD with IV injection of agitated saline. The tech-
nique consists of the injection of 20 ml of previously shaken saline
as contrast-enhancing agent into a peripheral vein, while recording
the flow velocity of the middle cerebral artery, insonated through
the temporal window on the right side at a depth of 50–60 mm,
with a hand-held probe. The appearance of transient spikes on the
velocity spectral curve within 10 s of the intravenous injection of
contrast medium is considered positive for interatrial right-to-left
shunt (Fig. 1). The method has been previously validated in our
institution and provides 90% sensitivity and 100% specificity, with
an overall diagnostic accuracy of 95%, in comparison with tran-
soesophageal echocardiography [5]. All contrast TCD were per-
formed with a standard MultiDop (Esaote) device equipped with a
2-MHz transducer by two experienced examiners (MG, PZ) who
were unaware of the status (MA+, MA– or CH) of the patients.
Results
The study group consisted of 372 patients (74 MA–; 260
MA+; 38 CH). PFO was detected in 161 subjects in the
subgroup of patients with MA+ (61.9%), 12 subjects in the
subgroup of patients with MA– (16.2%), and 14 subjects in
the subgroup of patients with CH (36.8%). When pheno-
type variables (frequency of migraine attack and complex-
ity of aura) were included in the analysis and their preva-
lence in each subgroup compared, no significant difference
was found (Table 1). Finally, among the 15 patients who
had a history of at least one migraine attack occurring dur-
ing strenuous physical exercise (Valsalva manoeuvre) only
one subject turned out to be a PFO-carrier.
Fig. 1 Multiple embolic signals detected on middle cerebral artery
Table 1 General characteristics, clinical presentation and prevalence of PFO in the study group
Characteristic MA+ MA– CH MA+ PFO+ MA+ PFO– MA–PFO+ MA– PFO– 
(n=260) (n=74) (n=38) (n=161) (n=99) (n=12) (n=62)
Sex, male, n (%) 98 (37.7) 29 (39.2) 23 (60.5) 60 (37.2) 38 (33.3) 5 (41.6) 24 (38.7)
Age, mean (SD), years 32 (7) 35 (5) 43 (4) 31 (5) 33 (8) 34 (7) 36 (5)
Migraine attacks/mo, mean (SD)* 1 (2) 5 (3) 1 (2) 1 (2) 5 (4) 5 (3)
Migraine attacks days/mo, mean (SD)* 1 (2) 11 (2) 1 (2) 1 (2) 10 (3) 11 (2)
Migraine attack severity, %*
Moderate 82 75 80 76 72 70
Severe 18 25 20 24 28 30
Aura, n (%)
Visual disturbances 259 (99.6) 160 (99.3) 99 (100)
Sensory disturbances 145 (55.7) 85 (57.9) 60 (60.6)
Diphasic disturbances 46 (17.6) 30 (18.6) 16 (16.1)
Typical aura without headache, n (%) 0 (0.0) 0 (0.0) 0 (0.0)
Typical aura with non-migraine, n (%) 38 (14.6) 26 (16.1) 12 (12.1)
Typical aura with migraine headache, n (%) 222 (85.4) 141 (87.5) 81 (81.1)
PFO carriers, n (%) 161 (61.9) 12 (16.2) 14 (36.8)
*In the last six months
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Discussion
Our findings support the assumption of an association
between PFO and MA+. In contrast, given the low preva-
lence of PFO among patients with MA–, the possibility that
this interatrial abnormality may have a pathogenic role in
such specific subgroup seems unlikely. Based on the results
of the present study, the hypothesis of an influence of PFO
on the pathogenesis of CH is also plausible. Our observation
of a negative PFO–MA– association is apparently inconsis-
tent with the results of recent observational studies in which
a reduction of the frequency of migraine attacks was found
after percutaneous closure of PFO in both the subgroups of
patients with MA+ and MA– [6]. Although we cannot rule
out the possibility of an underpowered analysis given the
relatively small number of MA– patients in our group, it
might be that the beneficial effect of PFO-closure on MA–
may be dependent on additional, and still unknown, co-
existing factors, such as, for instance, the clinical presenta-
tion of disease. Although this is biologically plausible, strat-
ification for the phenotypic subcategories we identified did
not change our results. The same is true for the potential role
of paradoxical embolism. As no interaction was observed
among migraine occurrence, the triggering effect of Valsalva
manoeuvre and PFO, we do not believe that such a mecha-
nism may have any pathogenic influence. These findings
prompt speculation that factors different from those predict-
ed by phenotype might be operant in the complex relation
between PFO and migraine. Overall, the exact pathogenic
role of PFO in migrainous disorders remains debatable. On
the basis of these observations, a therapeutical randomised
case-control trial of percutaneous PFO closure in patients
with different migraine subtypes has been designed and will
be carried out in our institution.
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